Lifearc
LifeArc Ventures: Investing in early-stage life science companies, offering scientific insight, advice, and venture funding.
LifeArc Ventures: Investing in early-stage life science companies, offering scientific insight, advice, and venture funding.
lifearc.orgCrawled Oct 15, 2026
MRC Technology moved its Centre for Therapeutics Discovery to laboratory facilities at the SBC campus; some teams are also relocating from its central London office. The charity retains a London office and has laboratories and an office in Edinburgh.
The company offers a flex fund equal to 5% of basic salary, which can be used for selected benefits or paid as cash. The page also lists 31 days among its core benefits.
The company offers flexibility and a work environment, and builds diverse teams to support its mission of getting treatments to patients faster.
The company describes equity, diversity and inclusion as fundamental to its organisation and says it aims to create a diverse, flexible and equitable work environment where people can thrive as themselves.
Ian Gillam is Chair of LifeArc Board of Trustees.
Sameer Mistry serves on the Audit and Risk Management Committee and is a senior industry physician leader with more than 18 years’ experience in pharmaceuticals, medical devices and consumer healthcare. He is Global Medical Lead, Early Drug Development at GSK.
The company’s executive team manages day-to-day activities. Its trustees bring expertise in biomedical sciences, biotech, pharma, finance, law and medicine, and oversee and support its strategy and charitable aims.
The company is a self-funded medical research organisation focused on transforming lives affected by rare diseases and drug-resistant infections. It conducts and funds research and works with partners to translate scientific breakthroughs into tests and treatments.
Timeline
The company’s investment portfolio stood at £1.255 billion in December 2024. Collaborative projects can generate royalty interests, and the company monetised part of those interests in 2019.
The company says measuring its impact is complex because its contributions often support early-stage research. Discoveries can take a decade or more to reach patients, and some do not progress through later development phases.
The company has an office in London and scientific research facilities in Stevenage and Edinburgh, as well as a specialist science team at the Francis Crick Institute in London.
The company draws on 30 years of experience in antibody humanisation, diagnostics, biomarker development and drug development. It funds promising science and partners with others to advance research toward commercial viability.
GitHubRepository owner